dasatinib krka
krka, d.d., novo mesto - dazatinibas - plėvele dengtos tabletės - 70 mg - dasatinib
dasatinib krka
krka, d.d., novo mesto - dazatinibas - plėvele dengtos tabletės - 80 mg - dasatinib
dasatinib krka
krka, d.d., novo mesto - dazatinibas - plėvele dengtos tabletės - 100 mg - dasatinib
dasatinib krka
krka, d.d., novo mesto - dazatinibas - plėvele dengtos tabletės - 140 mg - dasatinib
dasatinib zentiva
zentiva k.s. - dazatinibas - plėvele dengtos tabletės - 50 mg - dasatinib
dasatinib zentiva
zentiva k.s. - dazatinibas - plėvele dengtos tabletės - 100 mg - dasatinib
dasatinib accord
accord healthcare s.l.u. - dasatinibas - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antinavikiniai vaistai - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinibas - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antinavikiniai vaistai - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
eylea
bayer ag - aflibercept - wet macular degeneration; macular edema; diabetes complications - oftalmologai - eylea yra nurodyta suaugusiųjų gydymas:neovascular (šlapias) su amžiumi susijusios geltonosios dėmės degeneracija (amd);regos sutrikimų, dėl geltonosios dėmės edema antrinio tinklainės venų užakimas (filialas rvo ar centrinio rvo);regos sutrikimų, dėl diabetinės geltonosios dėmės edema (dme);regos sutrikimų, dėl trumparegiško choroidal neovascularisation (trumparegis cnv).
noflamen
egis pharmaceuticals plc - meloksikamas - tabletės - 7,5 mg; 15 mg - meloxicam